18 September 2020>: Original Paper
ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
Shih-Chao Hsu 123ABCDEF , Ashok Thorat 13ABCEF , Long-Bin Jeng 123ABCDEF* , Ping-Chun Li 134ADF , Chun-Chieh Yeh 123BE , Te-Hung Chen 123BCF , Horng-Ren Yang 123BDE , Kin-Shing Poon 35DFDOI: 10.12659/AOT.923502
Ann Transplant 2020; 25:e923502
Figure 6 Survival analysis comparing ABO-i LDLT and ABO-compatible LDLT patients.